Exploring the Anti-Cancer Mechanism of Novel 3,4'-Substituted Diaryl Guanidinium Derivatives
We previously identified a guanidinium-based lead compound that inhibited BRAF through a hypothetic type-III allosteric mechanism. Considering the pharmacophore identified in this lead compound (i.e., "lipophilic group", "di-substituted guanidine", "phenylguanidine polar end...
Saved in:
Main Authors: | Viola Previtali (Author), Helene B. Mihigo (Author), Rebecca Amet (Author), Anthony M. McElligott (Author), Daniela M. Zisterer (Author), Isabel Rozas (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives
by: Francesco Saccoliti, et al.
Published: (2017) -
Synthesis of Substituted Cyclohexenones from the Condensation of Acetone with 1,3-Diaryl-2-propen-1-one
by: Abdul-Wahab
Published: (2010) -
Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety
by: Sedighe Sadeghian-Rizi, et al.
Published: (2018) -
Diaryl azo derivatives as anti-diabetic and antimicrobial agents: synthesis, in vitro, kinetic and docking studies
by: Tehreem Tahir, et al.
Published: (2021) -
Design, Synthesis, Antimicrobial Properties, and Molecular Docking of Novel Furan-Derived Chalcones and Their 3,5-Diaryl-∆<sup>2</sup>-pyrazoline Derivatives
by: Inas S. Mahdi, et al.
Published: (2023)